Codetta Bio Inc. — Form D/A
Codetta Bio Inc. of MORRISVILLE, NC, a company, filed a Form D amendment with the SEC on 2024-10-30. The offering totals $26.4M, of which $12.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-30
- Form: D/A
- Accession: 0002025372-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.4M
- Amount sold: $12.3M
- Remaining: $14.2M
- Investors: 4
- Date of first sale: 2024-05-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515143
Issuer
- Name: Codetta Bio Inc.
- CIK: 0002025372
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 140 SOUTHCENTER CT., MORRISVILLE, NC, 27560
- Phone: 919-619-4324
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jacques Corriveau | Director | Morrisville, NC |
| John Michael Ho | Director | Morrisville, NC |
| J. Michael Ramsey | Director | Morrisville, NC |
| Jacques Corriveau | Executive Officer | Morrisville, NC |
| William Hampton Henley | Executive Officer | Morrisville, NC |
Other filings by this issuer (1)
More